New Imidazole-Based Compounds Active Against Trypanosoma cruzi.

Comb Chem High Throughput Screen

Departamento de Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, Pza. Ramón y Cajal s/n, 28040 Madrid. Spain.

Published: October 2017

Background: Current drugs available for the treatment of Chagas disease are fraught with several challenges including severe toxicity and limited efficacy. These factors coupled with the absence of effective drugs for treating the chronic stage of the disease have rendered the development of new drugs against Chagas disease a priority.

Objective: This study screened several imidazole-based compounds for anti-Trypanosoma potential.

Method: Using an in vitro experimental infection model, several imidazole-based compounds were screened for anti-proliferative effect on Trypanosoma cruzi epimastigotes. Additionally, all test compounds were evaluated for unspecific cytotoxicity on L929 murine fibroblasts. Benznidazole (BZN) served as reference drug.

Results: All test compounds demonstrated interesting trypanocidal potential with IC50 values in the μM range (1< 1C50 <8 μM). The activities of the test compounds compared favorably with BZN, which had an IC50 value ca. 30 μM. Conversely, most of the test compounds were highly cytotoxic, resulting in selectivity lower than that of BZN (SI > 9.42).

Conclusion: We provide evidence which implicate the imidazole-based compounds as potential prototypes for the development of anti-parasitic agents. Findings have far-reaching relevance to drug discovery efforts for trypanosomiasis.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1386207320666170110141907DOI Listing

Publication Analysis

Top Keywords

imidazole-based compounds
16
trypanosoma cruzi
8
chagas disease
8
test compounds
8
compounds
5
imidazole-based
4
compounds active
4
active trypanosoma
4
cruzi background
4
background current
4

Similar Publications

Context: High nitrogen and high-density compounds have become popular research objects in the energetic materials in recent years. Among them, compounds composed of triazine and azole skeleton rings have received attention due to their good stability and nitrogen content. The triazine imidazole-based condensed ring energetic derivatives have good properties and lack research on the direction of thermal decomposition.

View Article and Find Full Text PDF

Theoretical exploration of energetic molecular design strategy: functionalization of C or N and structural selection of imidazole or pyrazole.

J Mol Model

October 2024

Hubei Sanjiang Aerospace Jianghe Chemical Technology Co, Ltd , Hubei, 443000, People's Republic of China.

Context: In researching energetic materials with high energy density, it is an effective method to introduce explosophoric groups. In this study, four series of energetic compounds were designed by functionalizing with C- or N-, introducing energetic groups -CH(NO), -CF(NO), -C(NO)(NF), -C(NO), and-CH(NF) into imidazole and pyrazole structures. Density functional theory was employed to optimize the structure of the target compound and subsequently to predict and evaluate its performance based on this.

View Article and Find Full Text PDF

Design, synthesis and biological evaluation of novel benzimidazole-derived p21-activited kinase 4 (PAK4) inhibitors bearing a 4-(4-methylpiperazin-1-yl)phenyl scaffold as potential antitumor agents.

Eur J Med Chem

December 2024

School of Pharmacy, Key Laboratory of Research and Development of Small Molecule Targeted Antitumor Drugs, China Medical University, Shenyang 110122, PR China. Electronic address:

A series of novel 6-(4-(4-methylpiperazin-1-yl)phenyl)-1H-benzo[d]imidazole-based p21-activited kinase 4 (PAK4) inhibitors were designed and synthesized based on the structure of lead compound GNE-2861 and that of anticancer inhibitors reported in our previous studies. All target compounds so designed were preliminarily screened in vitro for anti-tumor potency through kinase inhibitory assays and MTT assays, which revealed that most compounds exhibited significant inhibitory effects on PAK4 enzyme as well as prominent antiproliferative activities against four cancer cell models (A549, NCI-H1975, MDA-MB-231 and SK-BR-3) and low damage to healthy cells. In particular, the hit compound 12i was identified as the most effective and rather selective compound both at the enzyme and cellular level.

View Article and Find Full Text PDF

Inorganic scale formation is a common issue in multi-stage flash (MSF) desalination plants, significantly impacting operational efficiency. To address this, acid cleaning is frequently employed, but it can lead to severe corrosion of alloy components if not properly controlled with corrosion inhibitors. This study investigates the effectiveness of toluene-2,4-diisocyanate-4-(1H-imidazole-ly) aniline (TDIA) as a corrosion inhibitor for 304L stainless steel in a simulated acid cleaning solution (1M HCl and 3.

View Article and Find Full Text PDF

Molecular modelling and experimental validation identified a new therapeutic inhibitor of toxoplasmosis.

Comput Biol Med

December 2024

Laboratory of Sustainable Animal Environment Systems, Graduate School of Agricultural Sciences, Tohoku University, Japan. Electronic address:

Article Synopsis
  • Toxoplasmosis, caused by the parasite Toxoplasma gondii, affects about one-third of humans, and there's a need for new treatments due to the lack of effective options.
  • Researchers used computational methods to screen 3000 compounds, ultimately identifying nine candidate compounds that were tested against T. gondii in the lab.
  • Among these, C5 showed promising anti-parasitic effects by inhibiting parasite growth and replication, while also increasing reactive oxygen species levels, although it exhibited some toxicity towards host cells as well.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!